This is the authors' abstract. We don't add key points for this paper.
Glycosyltransferases and glycosidases work together to construct the oligosaccharide moieties of biologically active glycoconjugates. Although many excellent glycosidase inhibitors have been developed, some of which are in clinical use, there are relatively few promising candidates of glycosyltransferase inhibitors. In this review, we summarize the current state of the development of glycosyltransferase inhibitors.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kajimoto et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: